Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 47,659 · FY2024 125,109 — 3-yr total 172,768
Georgia Capital is a London-listed (LSE: CGEO) investment holding company with portfolio investments in Georgian healthcare, retail (pharmacy), insurance, beverages, real estate (m2), and renewable energy.
Group parent — controls 3 companies · ownership
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 921 | 177,482 | 260,932 | 1,283 | 74,640 | 100,469 | 155,004 | 122,679 | nmf |
| Net Cash used in Investing Activities | 0 | 541,342 | 455,185 | 49,159 | 162,125 | 490,374 | 82,376 | 161,783 | nmf |
| Free Cash Flow (OCF − Capex proxy) | 921 | 363,860 | 194,253 | 47,876 | 87,485 | 590,843 | 237,380 | 284,462 | nmf |
| Net Cash from Financing Activities | 0 | 279,493 | 61,143 | 52,068 | 62,725 | 467,901 | 378,218 | 169,519 | nmf |
| Net Change in Cash (before FX) | 921 | 84,367 | 133,110 | 4,192 | 24,760 | 122,942 | 140,838 | 114,943 | nmf |
| Effect of FX on Cash | 0 | 8,523 | 3,024 | 4,003 | 2,552 | 12,885 | 7,795 | 1,720 | nmf |
| Net Change in Cash (incl. FX) | 921 | 92,890 | 136,134 | 189 | 27,312 | 110,057 | 148,633 | 116,663 | nmf |
| Cash at Beginning of Year | 0 | 346,239 | 253,349 | 117,215 | 117,026 | 89,714 | 199,771 | 51,138 | -27.3% |
| Cash at End of Year | 0 | 253,349 | 117,215 | 117,026 | 89,714 | 199,771 | 51,138 | 167,801 | -6.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →